Clinical Trials on Hypertension

Total 11121 results

The Third Xiangya Hospital of Central South University

Completed

Low-dose Quadruple Combination Therapy in Patients With Hypertension (QUADUAL)

Hypertension | Arterial Hypertension

China
HK inno.N Corporation

Completed

A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil Monotherapy

Essential Hypertension

Korea, Republic of
HK inno.N Corporation

Completed

A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Amlodipine Besylate Monotherapy

Essential Hypertension

Korea, Republic of
Quantum Genomics SA
PRA Health Sciences

Terminated

Randomized Study of Extended Treatment With Firibastat in Treatment-Resistant Hypertension (REFRESH) (REFRESH)

Hypertension (HTN)

United States, Canada
T.C. ORDU ÜNİVERSİTESİ

Completed

Hypertension Patients on Drug Medication Adherence and Rational Medication Use

Hypertension Patients

Turkey
Institute of Nutrition of Central America and Panama
National Heart, Lung, and Blood Institute (NHLBI); Institute for Clinical Effectiveness... and other collaborators

Completed

Multicomponent Intervention to Improve Hypertension Control in Central America

Arterial Hypertension

Guatemala
EMS

Withdrawn

Efficacy and Safety of Leningrado Association in the Treatment of Hypertension

Arterial Hypertension
Hanmi Pharmaceutical Company Limited

Completed

A Phase 2 Study to Explore the Dose of HCP1803 in Patients With Essential Hypertension (HM_APOLLO)

Hypertension

Korea, Republic of
Johns Hopkins University
Patient-Centered Outcomes Research Institute; National Heart, Lung, and Blood...

Completed

Reducing Inequities in Care of Hypertension, Lifestyle Improvement for Everyone (RICH LIFE Project) (RICH LIFE)

Uncontrolled Hypertension

United States
Hospices Civils de Lyon

Terminated

Descriptive Study of Drug Compliance in Uncontrolled Hypertensive Patients (THERMO-HTA)

Uncontrolled Hypertension

France
Kalos Medical

Completed

DENEX Renal Denervation in Patients With Uncontrolled Hypertension: Safety Study

Uncontrolled Hypertension

Korea, Republic of
Theracos

Completed

An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension

Essential Hypertension

United States
Menarini Group
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

Completed

Olmesartan/HCTZ 40/12.5 mg Combination Therapy Versus Olmesartan Medoxomil 40 mg Monotherapy in Essential Hypertension

Hypertension

Poland, Germany, Israel, Romania, Italy, Denmark, Czechia, Croatia
Servier Russia

Completed

The Use of TrIple Fixed-dose Combination in the Treatment of Arterial Hypertension (TRICOLOR)

Arterial Hypertension

Russian Federation
EMS

Withdrawn

Efficacy and Safety of Leningrado 5 Association in the Treatment of Hypertension

Arterial Hypertension
Boryung Pharmaceutical Co., Ltd

Completed

FimasaRtan-basEd BP Targets After Drug SwitcHing (FRESH)

Essential Hypertension

Korea, Republic of
University of Texas Southwestern Medical Center
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Mechanisms and Treatment of Intradialytic Hypertension (MATCH)

Intradialytic Hypertension

United States
Roland E. Schmieder
Institute for Preventive Medicine

Completed

Patient Preference in Blood Pressure Therapy

Arterial Hypertension

Germany
Daiichi Sankyo Co., Ltd.

Completed

Long-term Study of CS-3150 as Monotherapy or in Combination With Other Antihypertensive Drug in Japanese Patients With Essential Hypertension

Essential Hypertension

Japan
Daiichi Sankyo, Inc.

Completed

A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Hypertensive Subjects

Essential Hypertension

Japan
Merinal Laboratoires
Axelys Sante Dz

Completed

Diagnosis and Management of Arterial Hypertension for Algerian Patients in Current Medical Practice (MAPADZ)

Arterial Hypertension

Algeria
Directed Systems Limited
University Hospital Birmingham

Unknown

Collection of Anonymised Blood Pressure Data During High Risk Surgery

Perioperative Hypertension
Western Galilee Hospital-Nahariya

Completed

Hemodynamic Parameters Changes in the Course of Hemodialysis Sessions in Patients With Intradialytic Hypertension

Intradialytic Hypertension

Israel
Merck Sharp & Dohme LLC

Completed

MK-0954E Study in Participants With Hypertension (MK-0954E-357)

Hypertension
Boryung Pharmaceutical Co., Ltd

Completed

Post-Authorization Long-term Safety Surveillance on Antihypertensive Treatment With Kanarb® (Fimasartan)

Essential Hypertension

Korea, Republic of
Abbott Medical Devices

Completed

EnligHTN German Observational Study of Renal Denervation for Uncontrolled Hypertension

Uncontrolled Hypertension

Germany
Daiichi Sankyo, Inc.

Completed

Parallel-Group Comparison of Olmesartan (OLM), Amlodipine (AML) and Hydrochlorothiazid (HCTZ) in Hypertension

Essential Hypertension

Italy, Poland, Ukraine, Germany, Spain, Bulgaria, Romania, Denmark, Belgium, Netherlands, Russian Federation, Hungary, Slovakia, Czechia, Latvia
Daiichi Sankyo, Inc.
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

Completed

Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension

Essential Hypertension

France, Poland, Ukraine, Germany, Spain, Bulgaria, Czechia
Sankyo Pharma Gmbh

Completed

Amlodipine as add-on to Olmesartan in Hypertension

Essential Hypertension

Germany
Daiichi Sankyo Korea Co., Ltd., a Daiichi Sankyo...

Completed

Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Combination Therapy in Patients With Hypertension Not Controlled With Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy

Essential Hypertension

Korea, Republic of
Pfizer

Completed

Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension (OSCAR)

Essential Hypertension

Colombia, Singapore, Taiwan, Thailand, Ecuador, Indonesia, Philippines, Hong Kong, Malaysia, Turkey
ReCor Medical, Inc.

Completed

TrAnsCatHeter Intravascular Ultrasound Energy deliVery for rEnal Denervation (ACHIEVE) (ACHIEVE)

Resistant Hypertension

Germany, Sweden, Netherlands
University of Warmia and Mazury
Zaklady Farmaceutyczne Polpharma SA / Poland

Active, not recruiting

Arterial Hypertension in Men in the Warmia and Masuria Region (ProM)

Arterial Hypertension

Poland
University of Texas Southwestern Medical Center
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Mechanisms of Increased Ambulatory Blood Pressure in Patients With Intradialytic Hypertension

Intradialytic Hypertension

United States
Madigan Army Medical Center
Telemedicine & Advanced Technology Research Center; Analytics4Medicine, Inc.

Unknown

Uncontrolled Hypertension Management (TEAM-HTN) (TEAM-HTN)

Uncontrolled Hypertension

United States
Roxane Laboratories

Completed

Bioequivalency Study of Perindopril Erbumine 8 mg Tablet Under Fasted Conditions

Essential Hypertension

United States
University of Erlangen-Nürnberg Medical School

Completed

Aliskiren on Retinal Vasculature Treatment Study (ARTS)

Arterial Hypertension

Germany
Daiichi Sankyo Co., Ltd.

Completed

Calcium Channel Blockers (CCBs) or Diuretics as an Add-on to Olmesartan Medoxomil in Hypertension

Hypertension

Japan
Medtronic Vascular

Completed

Renal Denervation by MDT-2211 System in Patients With Uncontrolled Hypertension (HTN-J)

Uncontrolled Hypertension

Japan
Proteus Digital Health, Inc.

Completed

Helius in Hypertension-I: The UK Hypertension Registry

Essential Hypertension
Takeda

Withdrawn

An Efficacy and Safety Study Evaluating the Fixed-Dose Combination of Candesartan Plus Amlodipine in Participants With Mild/Moderate Essential Hypertension

Hypertension

China
Novartis Pharmaceuticals

Completed

Study of Efficacy and Safety of CVAA489 in Hypertensive Patients

Essential Hypertension

Turkey
Merck KGaA, Darmstadt, Germany
Merck Serono Co., Ltd., China

Completed

A Randomized Controlled Study to Assess the Effects of Bisoprolol and Atenolol on Resting Heart Rate and Sympathetic Nervous System's Activity in Subjects With Essential Hypertension

Hypertension

China
Novartis Pharmaceuticals

Completed

Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Asian Patients With Essential Hypertension

Essential Hypertension

China, Korea, Republic of, Taiwan, Hong Kong, Thailand, Philippines, Singapore
GlaxoSmithKline

Completed

Research Study To Test Carvedilol CR + Lisinopril Versus Lisinopril + Placebo In Patients With High Blood Pressure

Hypertension

United States
IlDong Pharmaceutical Co Ltd

Completed

Efficacy and Safety of TAH Combination in Comparison With Telmisartan/Amlodipine Combination for Essential Hypertension Patients

Essential Hypertension

Korea, Republic of
Aarhus University Hospital Skejby
Aarhus University Hospital; Regional Hospital Holstebro; Regionshospitalet Silkeborg and other collaborators

Completed

Renal Sympathectomy in Treatment Resistant Essential Hypertension, a Sham Controlled Randomized Trial (ReSET)

Hypertension

Denmark
Jagiellonian University

Completed

Physical Exercises Influence on Blood Pressure and Arterial Stiffness

Arterial Hypertension
Boryung Pharmaceutical Co., Ltd
Asan Medical Center; Ulsan University Hospital; Korea University Anam Hospital; Dong-A University and other collaborators

Completed

A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension (fimasartan)

Hypertension

Korea, Republic of
Chengdu University of Traditional Chinese Medicine
Hunan University of Traditional Chinese Medicine

Completed

Effect of Acupuncture on Patients With Mild Hypertension (EAPMH)

Essential Hypertension

China

Clinical Trials on Hypertension

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Algeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations